Sotera Health (NASDAQ:SHC) Shares Acquired by Vanguard Group Inc.

Vanguard Group Inc. lifted its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,923,546 shares of the company's stock after buying an additional 173,341 shares during the quarter. Vanguard Group Inc. owned about 5.27% of Sotera Health worth $204,154,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Xponance Inc. lifted its position in shares of Sotera Health by 6.0% during the 4th quarter. Xponance Inc. now owns 17,495 shares of the company's stock worth $239,000 after buying an additional 989 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Sotera Health by 2.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company's stock valued at $711,000 after purchasing an additional 1,047 shares during the last quarter. GAMMA Investing LLC raised its position in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after purchasing an additional 1,121 shares during the last quarter. Blue Trust Inc. raised its position in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its position in Sotera Health by 17.3% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock valued at $217,000 after purchasing an additional 2,340 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Performance

SHC traded down $0.52 during trading on Thursday, hitting $10.80. The stock had a trading volume of 156,291 shares, compared to its average volume of 1,163,292. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm has a market capitalization of $3.06 billion, a P/E ratio of 43.20 and a beta of 1.88. The company's 50-day moving average price is $12.28 and its 200 day moving average price is $13.61. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08.

Analyst Upgrades and Downgrades

Separately, Barclays dropped their price objective on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research note on Friday, February 28th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Sotera Health currently has a consensus rating of "Moderate Buy" and an average target price of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.